Copyright
©The Author(s) 2015.
World J Cardiol. Nov 26, 2015; 7(11): 792-800
Published online Nov 26, 2015. doi: 10.4330/wjc.v7.i11.792
Published online Nov 26, 2015. doi: 10.4330/wjc.v7.i11.792
Variable | Total (n = 200) | BTT (n = 98) | DT (n = 102) | P value |
Age (yr) | 54.3 ± 12.5 | 50.1 ± 12.8 | 58.4 ± 10.7 | 0.001 |
Gender | ||||
Female | 24% (48/200) | 25.5% (25/98) | 22.8% (23/102) | |
Male | 76% (151/200) | 74.5% (73/98) | 76.5% (78/102) | 0.652 |
Race | ||||
AA | 46% (92/200) | 39.8% (39/98) | 52% (53/102) | 0.375 |
Caucasian | 54% (108/200) | 54.1% (53/98) | 42.4% (47/102) | |
Etiology of heart failure | ||||
ICM | 52% (104/200) | 29% (28/98) | 74.5% (76/102) | 0.001 |
NIDCM | 48% (96/200) | 51% (50/98) | 45.1% (46/102) | |
BSA | 1.97 ± 0.27 | 1.96 ± 0.27 | 1.98 ± 0.28 | 0.667 |
BMI | 28.3 ± 5.5 | 28.1 ± 4.3 | 28.5 ± 6.5 | 0.763 |
Albumin (g/dL) | 4.14 ± 10.03 | 3.19 ± 0.51 | 5.06 ± 14.05 | 0.015 |
DM | 46% (92/200) | 38.8% (38/98) | 52.9% (54/102) | 0.038 |
HTN | 83% (166/200) | 79.6% (78/98) | 86.2% (88/102) | 0.153 |
CRI | 40% (81/200) | 29.6% (29/98) | 51% (52/102) | 0.002 |
Dialysis | 2.5% (5/200) | 3.1% (3/98) | 1.8% (2/102) | 0.680 |
COPD | 15.5% (31/200) | 15.3% (15/98) | 15.7% (16/102) | 0.917 |
PVD | 12% (23/200) | 7.1% (7/98) | 15.7% (16/102) | 0.055 |
Vented | 12% (25/200) | 9.2% (9/98) | 15.7% (16/102) | 0.134 |
Previous cardiac surgery | 32% (63/200) | 20.4% (20/98) | 42% (43/102) | 0.001 |
Creatinine (mg/dL) | 1.42 ± 0.62 | 1.43 ± 0.58 | 1.42 ± 0.65 | 0.869 |
AST (U/L) | 48.3 ± 82.8 | 58.0 ± 106.8 | 38.9 ± 45.7 | 0.212 |
ALT (U/L) | 46.5 ± 78.5 | 59.8 ± 99.4 | 33.5 ± 47.3 | 0.002 |
CPB time (min) | 113.5 ± 46.1 | 109.5 ± 46.0 | 117.8 ± 46.1 | 0.178 |
XCL time (min) | 71 ± 30.6 | 85.2 ± 33.7 | 51.7 ± 26.0 | 0.054 |
MCS at time of VAD | 18% (36/200) | 24% (23/98) | 13% (13/102) | 0.051 |
On inotropes at time of VAD | 75%(150/200) | 81% (80/98) | 69% (70/102) | 0.036 |
Pre VAD CVP (mmHg) | 11.8 ± 6.4 | 11.6 ± 6.4 | 12.0 ± 6.4 | 0.653 |
Pre VAD PAPs (mmHg) | 51.4 ± 14.2 | 50.5 ± 14.5 | 52.3 ± 13.8 | 0.412 |
Pre VAD PAPd (mmHg) | 24.5 ± 9.2 | 24.4 ± 9.8 | 24.7 ± 8.5 | 0.682 |
Pre Vad CI (L/min per square metre) | 1.85 ± 0.51 | 1.87 ± 0.54 | 1.83 ± 0.47 | 0.961 |
Pre VAD PCWP (mmHg) | 23.0 ± 9.6 | 22.7 ± 9.8 | 23.4 ± 9.4 | 0.463 |
Blood transfusions | 23% (46/200) | 18% (18/98) | 27% (28/102) | 0.250 |
Concomitant cardiac procedure | 19% (39/200) | 23% (23/98) | 15% (16/102) | 0.137 |
- Citation: Tsiouris A, Paone G, Nemeh HW, Borgi J, Williams CT, Lanfear DE, Morgan JA. Short and long term outcomes of 200 patients supported by continuous-flow left ventricular assist devices. World J Cardiol 2015; 7(11): 792-800
- URL: https://www.wjgnet.com/1949-8462/full/v7/i11/792.htm
- DOI: https://dx.doi.org/10.4330/wjc.v7.i11.792